Ho-Yeong Lim

1.8k total citations
31 papers, 863 citations indexed

About

Ho-Yeong Lim is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ho-Yeong Lim has authored 31 papers receiving a total of 863 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 8 papers in Surgery. Recurrent topics in Ho-Yeong Lim's work include Gastric Cancer Management and Outcomes (7 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Ho-Yeong Lim is often cited by papers focused on Gastric Cancer Management and Outcomes (7 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Hepatocellular Carcinoma Treatment and Prognosis (4 papers). Ho-Yeong Lim collaborates with scholars based in South Korea, United States and Japan. Ho-Yeong Lim's co-authors include Jin‐Hyuk Choi, Keunchil Park, Jeeyun Lee, Myung‐Ju Ahn, Won Ki Kang, Hyun Woo Lee, Seung Soo Sheen, Ho Yun Lee, Kyung Soo Lee and Ji Hye Min and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Surgery.

In The Last Decade

Ho-Yeong Lim

31 papers receiving 855 citations

Peers

Countries citing papers authored by Ho-Yeong Lim

Since Specialization

Citations

This map shows the geographic impact of Ho-Yeong Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ho-Yeong Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ho-Yeong Lim more than expected).

Fields of papers citing papers by Ho-Yeong Lim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ho-Yeong Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ho-Yeong Lim. The network helps show where Ho-Yeong Lim may publish in the future.

Co-authorship network of co-authors of Ho-Yeong Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Ho-Yeong Lim. A scholar is included among the top collaborators of Ho-Yeong Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ho-Yeong Lim. Ho-Yeong Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and anti-tumor effects of vismodegib in patients with refractory advanced gastric cancer: A single-arm, phase-II trial 2022 ·Journal of Cancer ·Ryul Kim, Jun Ji, Jung Hoon Kim, Jung Yong Hong, Ho-Yeong Lim, Won Ki Kang, Jeeyun Lee, Seung Tae Kim	5
2	Effect of pembrolizumab (pembro) on hepatitis B viral (HBV) load and aminotransferase (ALT) levels in patients (pts) with advanced hepatocellular carcinoma (aHCC) in KEYNOTE-224 and KEYNOTE-240. 2020 ·Journal of Clinical Oncology ·Stephen L. Chan, Andrew X. Zhu, Richard S. Finn, Julien Edeline, Sadahisa Ogasawara, Jennifer J. Knox, Bruno Daniele, Baek‐Yeol Ryoo, Philippe Merle, Mohamed Bouattour, Ho-Yeong Lim, Yee Chao, Thomas Yau, Barbara Haber, Usha Malhotra, Chih‐Chin Liu, Masatoshi Kudo, Ann‐Lii Cheng	3
3	Systematic Evaluation of Gastric Tumor Cell Index and Two-Drug Combination Therapy via 3-Dimensional High-Throughput Drug Screening 2019 ·Frontiers in Oncology ·Sung Hee Lim, K. Jason, Dong Woo Lee, Ju-Sun Kim, Seung Tae Kim, Se Hoon Park, Bosung Ku, Joon Oh Park, Young Suk Park, Ho-Yeong Lim, Won Ki Kang, Do-Hyun Nam, Jeeyun Lee	5
4	Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1/2 inhibition 2016 ·Annals of Oncology ·S. T. Kim, Su‐Young Kim, Samuel J. Klempner, Jin Young Yoon, Namo Kim, (unknown), Heejin Bang, Kyoung‐Mee Kim, Woong‐Yang Park, Se Hoon Park, (unknown), Y. S. Park, Ho-Yeong Lim, Seung‐Hoon Lee, (unknown), Won Ki Kang, Jaebeom Lee	52
5	Increased risk of everolimus-associated acute kidney injury in cancer patients with impaired kidney function 2014 ·BMC Cancer ·(unknown), Ji Hyeon Park, Hye Ryoun Jang, Wooseong Huh, Ho-Yeong Lim, Yoon-Goo Kim, Dae Joong Kim, Ha Young Oh, Jung Eun Lee	16
6	Prediction of Disease-free Survival in Hepatocellular Carcinoma by Gene Expression Profiling 2013 ·Annals of Surgical Oncology ·Ho-Yeong Lim, Insuk Sohn, Shibing Deng, Jeeyun Lee, Sin Ho Jung, Mao Mao, Jiangchun Xu, Kai Wang, Stephanie T. Shi, Jae‐Won Joh, Yoon‐La Choi, Cheol-Keun Park	110
7	5-Fluorouracil, Mitomycin-C, and Polysaccharide-K versus Uracil-Ftorafur and Polysaccharide-K as Adjuvant Chemoimmunotherapy for Patients with Locally Advanced Gastric Cancer with Curative Resection 2013 ·Oncology Research and Treatment ·(unknown), (unknown), Hyun Woo Lee, (unknown), Joon Seong Park, Kwang‐Jae Lee, (unknown), Sang‐Uk Han, Soon Young Lee, Ho-Yeong Lim, Jin‐Hyuk Choi	6
8	Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight 2011 ·Cancer Chemotherapy and Pharmacology ·Ji Hye Min, Ho Yun Lee, Ho-Yeong Lim, Myung‐Ju Ahn, Keunchil Park, Man Pyo Chung, Kyung Soo Lee	69
9	Bax Predicts Outcome in Gastric Cancer Patients Treated with 5-fluorouracil, Leucovorin, and Oxaliplatin Palliative Chemotherapy 2010 ·Digestive Diseases and Sciences ·Seong Hyun Jeong, Jae Ho Han, Jang‐Hee Kim, Mi Sun Ahn, (unknown), Hyun Woo Lee, Seok Yun Kang, Joon Seong Park, Jin‐Hyuk Choi, Kwang Jae Lee, Seung Soo Sheen, Ho-Yeong Lim	30
10	Low Expression of Bax Predicts Poor Prognosis in Resected Non-small Cell Lung Cancer Patients with Non-squamous Histology 2008 ·Japanese Journal of Clinical Oncology ·Seong Hyun Jeong, Hyun Woo Lee, Jun Hyun Han, Seok Yun Kang, Jin‐Hyuk Choi, (unknown), (unknown), (unknown), Kwang Joo Park, Sung Chul Hwang, Seung Soo Sheen, (unknown), Jang‐Hee Kim, Ho-Yeong Lim	30
11	Palliative chemotherapy for non-transitional cell carcinomas of the urothelial tract 2008 ·Medical Oncology ·Jung Yong Hong, Moon Ki Choi, Ji Eun Uhm, Min Jae Park, Yong‐Seok Jee, Se Hoon Park, Joon Oh Park, Won Seog Kim, Won Ki Kang, Hyun Moo Lee, Han Yong Choi, Ho-Yeong Lim	23
12	Prognostic Stratification of High-risk Gastrointestinal Stromal Tumors in the Era of Targeted Therapy 2008 ·Annals of Surgery ·Cheol Keun Park, Eui Jin Lee, (unknown), Ho-Yeong Lim, Dong Il Choi, Jae Hyung Noh, Tae Sung Sohn, Sung Hoon Kim, Mi Jung Kim, (unknown), Kyoung‐Mee Kim	45
13	Egr‐1, a new downstream molecule of Epstein‐Barr virus latent membrane protein 1 2007 ·FEBS Letters ·Joo Hyun Kim, Won Seog Kim, Jung Hun Kang, Ho-Yeong Lim, Young Hyeh Ko, Chaehwa Park	19
14	Combination chemotherapy with paclitaxel and ifosfamide as the third-line regimen in patients with heavily pretreated small cell lung cancer 2007 ·Lung Cancer ·Sarah Park, Myung‐Ju Ahn, Jin Seok Ahn, Jeeyun Lee, Yong Sang Hong, Byeong-Bae Park, Sang Chul Lee, In Gyu Hwang, Joon Oh Park, Ho-Yeong Lim, Won Ki Kang, Keunchil Park	16
15	Endothelial progenitor cell differentiation using cryopreserved, umbilical cord blood-derived mononuclear cells 2007 ·Acta Pharmacologica Sinica ·Jun‐Ho Jang, (unknown), Jeongeun Choi, Young‐Jin Kim, Hyun Woo Lee, (unknown), (unknown), Jin‐Hyuk Choi, Ho-Yeong Lim, Hugh C. Kim	19
16	Expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with small cell lung cancer 2007 ·Lung Cancer ·Hyun Woo Lee, Jae Ho Han, Jang‐Hee Kim, Myoung-Hee Lee, Seong Hyun Jeong, Seok Yun Kang, Jin‐Hyuk Choi, Young Taik Oh, Kwang Joo Park, Sung Chul Hwang, Seung Soo Sheen, Ho-Yeong Lim	33
17	Clinical characteristics and prognosis according to the classification of myelodysplastic syndrome 2006 ·The Korean Journal of Internal Medicine ·Hyun Woo Lee, (unknown), (unknown), (unknown), Jun‐Ho Jang, Joon Seong Park, Jin‐Hyuk Choi, Ho-Yeong Lim, (unknown)	1
18	Prospective clinical study of surgical resection followed by CHOP in localized intestinal diffuse large B cell lymphoma 2006 ·Leukemia Research ·Jeeyun Lee, Won Seog Kim, Kihyun Kım, Jin Seok Ahn, Chul Won Jung, Ho-Yeong Lim, Won Ki Kang, Keunchil Park, Young Hyeh Ko, Young Ho Kim, Chi-Min Park, Sung Hyun Yoon, Woo Yong Lee, Ho Kyung Chun	30
19	Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts 2001 ·Lung Cancer ·Jin‐Hyuk Choi, (unknown), Ho-Yeong Lim, Dong Ki Nam, Hyun Soo Kim, (unknown), Mison Chun, Young Taik Oh, Seunghee Kang, Kwang Joo Park, Sung Chul Hwang, (unknown), (unknown)	35
20	Detection of Transforming Growth Factor-α in the Serum of Gastric Carcinoma Patients 1999 ·Oncology ·Jin‐Hyuk Choi, (unknown), Ho-Yeong Lim, Dong Ki Nam, Hyun Soo Kim, Sun Young Yi, (unknown), Woon Sup Han	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact